Navigation Links
New study identifies preferred method to assess patient reactions to radiation therapy
Date:9/25/2013

ATLANTA, GA The North Shore-LIJ Health System Department of Radiation Medicine presented a novel study to evaluate the reliability of different systems used by caregivers to assess toxicity for patients receiving radiation therapy. The study will be presented at the 55th Annual Meeting of the American Society of Therapeutic Radiation Oncology in Atlanta, GA.

During the course of radiation therapy, patients may experience reactions to their treatments. Typically, the severity of reactions is assessed by a radiation oncologist and nurse using a formal grading scheme. Research conducted by North Shore-LIJ's radiation oncologists evaluated the reliability of these grading systems by independent caregivers. The study assessed whether independent caregivers would assign the same grade to the same adverse reaction using a common grading scheme. Images of breasts that had undergone radiation in 30 breast cancer patients on skin care protocols were presented to radiation oncologists and nurses who were asked to assign grades independently based on their evaluation of the images and provide feedback explaining their choices. The assessments were then analyzed and the level of agreement among caregivers was determined using statistical methods.

As presented at ASTRO, the study determined that overall there was a significantly better agreement in the assessments based on the use of the Common-Terminology-Criteria-for-Adverse Events (CTCAE) scale, which was developed by the National Cancer Institute to standardize the assignment of grades across various caregivers. Analysis of the comments provided by the caregivers revealed a reliance on assessment criteria that was not necessarily explicit in the grading definitions.

"Establishing the reliability of the scale used to assess adverse reactions among different caregivers is an important step to enhance uniformity and consistency of the care to our patients," said Ajay Kapur, PhD, lead author of
'/>"/>

Contact: Emily Eng
eng3@nshs.edu
516-562-2670
North Shore-Long Island Jewish (LIJ) Health System
Source:Eurekalert

Page: 1 2

Related medicine news :

1. SU physicist develops model for studying tissue pattern formation during embryonic development
2. Study finds link between commonly prescribed statin and memory impairment
3. Professors at Purchase College and Columbia University Receive More Than $500,000 in Grants to Study New Ways to Reduce Anxiety Disorders
4. Penn Medicine study: Proton therapy cuts side effects for pediatric head and neck cancer patients
5. Study: Majority of patients who qualify for lifesaving heart treatment do not receive it
6. Mayo-led study: Drug fails to reduce diarrhea in patients receiving radiation therapy
7. Loyola study assesses use of fingerstick blood sample with i-STAT point-of-care device
8. Brain may rely on computer-like mechanism to make sense of novel situations, says CU-Boulder study
9. CDC, MGH study reveals that preventing malaria in travelers to West Africa reduces health costs
10. Perfume Industry Review of Natural & Synthetic Perfumes for Global & China Markets in a New Research Study Available at DeepResearchReports.com
11. Stronger sexual impulses may explain why men cheat more than women, study reveals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... 2014 Running season is in full ... aims to help runners keep running. Dr Shoshany will ... continue training. He has recently began implementing an expanded, ... Cold Laser Therapy, Graston technique and kinesiology taping to ... Dr Shoshany often combines chiropractic , and physical ...
(Date:7/30/2014)... It is often said the reason that most people ... life is because they only use about ten per cent of ... belief is only an erroneous myth propagated as an excuse ... only “smarter”. , So, success in life is defined not just ... hard for that success. Thankfully, some people have finally figured out ...
(Date:7/30/2014)... 2014 AttorneyOne.com, a recognized authority on ... information from the FDA on snacks . , ... snacks are recalled because they contain organic ... with salmonella. Salmonella can cause serious, fatal infections in ... can cause abdominal pain, vomiting, nausea, diarrhea, or fever. ...
(Date:7/30/2014)... With the accelerated aging of the ... as well as the improved medical care facilities ... industry has been developing quickly, especially in vitro ... in vitro diagnostics market size reached RMB22.98 billion, ... diagnostic reagents. , Chinese in vitro diagnostic ...
(Date:7/30/2014)... City, OK (PRWEB) July 30, 2014 ... City, but it’s Founders, Amber Clour and Ryan Fightmaster ... worldwide level. , Officially launched on July 26th of ... provide real support for others living the diabetic life. ... had, dreams pursued and inspirations, they believe other diabetics ...
Breaking Medicine News(10 mins):Health News:Chiropractor Helping Runners Keep Going with New Integrated Treatment Protocols 2Health News:Chiropractor Helping Runners Keep Going with New Integrated Treatment Protocols 3Health News:Brain Evolution System - #1 Brainwave Entrainment Meditation Program Review | Unleashing One’s Ultimate Potential Improving Mind Power – Vinamy 2Health News:Brain Evolution System - #1 Brainwave Entrainment Meditation Program Review | Unleashing One’s Ultimate Potential Improving Mind Power – Vinamy 3Health News:Various Snacks by Dancing Star Recalled: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Various Snacks by Dancing Star Recalled: AttorneyOne Monitors and Keeps Consumers Informed 3Health News:China Diagnostic Reagent Industry (biochemical, molecular & immunodiagnostic) 2016 Forecasts in New Research Report at ChinaMarketResearchReports.com 2Health News:China Diagnostic Reagent Industry (biochemical, molecular & immunodiagnostic) 2016 Forecasts in New Research Report at ChinaMarketResearchReports.com 3Health News:China Diagnostic Reagent Industry (biochemical, molecular & immunodiagnostic) 2016 Forecasts in New Research Report at ChinaMarketResearchReports.com 4Health News:Strangers Come Together to Form Diabetes Website: Real Messages of Hope and Inspiration 2
... say, Montelukast, a leukotriene-receptor antagonist (leukotrienes mediate inflammation // ... reactions), decreased incidents of asthma in young children by ... ,Researchers conducted a one-year study involving 549 children ... 278 of the children received low-dose montelukast once a ...
... considered till now that after delivery depressions, that had plagued new ... trauma of the delivery. As a result of this belief, many ... depression. A new study that comes in the recent issue of ... ,According to Deirdre Murphy of Dundee University, who had led ...
... treat patients with acute traumatic brain injury, may lead to ... & Tropical Medicine. ,British researchers had studied the ... brain injury. The study was conducted to see the effect ... results showed that there seems to be an increase in ...
... their mothers to see if there was a link between ... life and children's antisocial behavior by age 7 , researchers ... problems with conduct and more antisocial behavior . ,Results ... birth and the likeliness of antisocial behavior in children by ...
... to a recent study researchers say those in the ... // an increased risk of suicidal behavior . ... and other clinical conditions were studied. Patients taking SSRIs ... taking placebo. Researchers say they found no difference ...
... Quetiapine, a drug used to treat agitation in patients ... say researchers based on findings of a recent study ... patients were observed . Twenty-six of the patients received ... rivastigmine (a cholinesterase inhibitor also known as Exelon), and ...
Cached Medicine News:
(Date:7/29/2014)... -- Amgen (NASDAQ: AMGN ) today announced ... results include: , Total revenues increased 11 percent ... driven by strong performance across the portfolio, particularly Enbrel ... (denosumab) and XGEVA ® (denosumab). , ... higher revenues and a significant increase in the profitability ...
(Date:7/29/2014)... , July 29, 2014  Alexza Pharmaceuticals, Inc. (Nasdaq: ... participating in two healthcare conferences during the third quarter, ... Morgan Stanley Global Healthcare 2014 Conference.  Alexza,s corporate presentation ... The details on each event are below: ... 11, 2014 in Boston , MA.  ...
(Date:7/29/2014)... Md. , July 29, 2014  Synthetic Biologics, ... biologic and drug candidates targeting specific pathogens that cause ... of the unusual market activity in the Company,s stock, ... in accordance with its usual practice. The Company stated ... market activity. About Synthetic Biologics, Inc. ...
Breaking Medicine Technology:Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 2Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 3Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 4Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 5Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 6Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 7Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 8Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 9Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 10Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 11Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 12Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 13Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 14Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 15Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 16Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 17Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 18Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 19Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 20Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 21Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 22Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 23Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 24Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 25Alexza Pharmaceuticals Announces Participation in Upcoming Investor Conferences 2Alexza Pharmaceuticals Announces Participation in Upcoming Investor Conferences 3Synthetic Biologics, Inc. States that Its Policy is Not to Comment on Unusual Market Activity 2
... is little evidence to support the use of atypical ... approved purposes, even though many clinicians continue to commonly ... to a new report from the U.S. Department of ... and Quality (AHRQ). An article based on information in ...
... The Houston Business Journal recently announced that eCardio Diagnostics ... Fast 100, which included a distinguished list of 100 of ... eCardio was ranked No. 17 with a two-year growth ... to receive this prestigious award. "There were so ...
Cached Medicine Technology:"Off-Label" Use of Antipsychotic Drugs for Some Conditions Not Supported By Evidence 2eCardio Among Honorees of the Houston Business Journal's Fast 100 List for Second Consecutive Year 2
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medicine Products: